`
`From:
`Sent:
`To:
`Subject:
`Attachments:
`
`Dowd, Matthew J <MatthewDowd@andrewskurth.com>
`Thursday, May 26, 2016 12:10 PM
`Reister, Andrea
`Argentum v. UCB, IPR2016-00204
`IPR2014-00244 (denying joinder when first petition settled).pdf; Mylan Vimpat IPR
`joinder motion 5-25-16.pdf; Settlement Term Sheet - UCBVimpat 5-26-16.pdf
`
`Andrea:
`
`In view of the Board’s decision to institute trial, I provide an updated settlement term sheet for your and your client’s
`consideration. Additionally, as you may know, Mylan Pharmaceuticals has filed its own IPR petition and a motion for
`joinder. Notwithstanding Mylan’s petition and motion, Argentum remains amenable to amicably resolving the pending
`IPR with UCB. We provide, for your convenience, an exemplary Board decision denying joinder where the first petitioner
`settled prior to a decision on the joinder motion.
`
`We look forward to your response.
`
`Best regards,
`
`Matthew J. Dowd
`Partner
`
`Andrews Kurth LLP
`1350 I Street, NW, Suite 1100
`Washington, DC 20005
`202.662.2701 Phone
`202.974.9511 Fax
`202.573.3853 Cell
`MatthewDowd@andrewskurth.com
`vCard | Bio | andrewskurth.com | Twitter | Facebook
`
`
`
`Confidentiality Notice: The information contained in this email and any attachments to it may be legally privileged and
`include confidential information intended only for the recipient(s) identified above. If you are not one of those intended
`recipients, you are hereby notified that any dissemination, distribution or copying of this email or its attachments is strictly
`prohibited. If you have received this email in error, please notify the sender of that fact by return email and permanently
`delete the email and any attachments to it immediately. Please do not retain, copy or use this email or its attachments for
`any purpose, nor disclose all or any part of its contents to any other person. Andrews Kurth LLP operates as a limited
`liability partnership. Andrews Kurth (Middle East) DMCC is registered and licensed as a Free Zone company under the
`rules and regulations of DMCCA. Andrews Kurth (UK) LLP is authorized and regulated by the Solicitors Regulation
`Authority of England and Wales (SRA Registration No.598542). Thank you.
`
`1
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2034 - 1/1